Inventor · disambiguated record
Ingo Pragst
Also filed as: PRAGST INGO
5 granted patents·5 pending applications·15 citations·filing 2009–2024
75Inventor score
Top patents by PatentIndex Score
10 records- 0182US9987328B2Factor XII inhibitors for the administration with medical procedures comprising contact with artificial surfacesCSL BEHRING GMBH·Filed 2016·Granted Jun 5, 2018·4 cites·20 claims
- 0276US2024398914A1Combination therapy using a factor xii inhibitor and a c-1 inhibitorCSL BEHRING GMBH·Filed 2024·Application pending·0 cites
- 0375US8603979B2von Willebrand factor or factor VIII and von Willebrand factor for the treatment of coagulopathy induced by inhibitors of thrombocytesDICKNEITE GERHARD·Filed 2009·Granted Dec 10, 2013·4 cites·24 claims
- 0474US9352016B2Factor XII inhibitors for the administration with medical procedures comprising contact with artificial surfacesZEITLER STEFAN·Filed 2012·Granted May 31, 2016·5 cites·17 claims
- 0567US2020129600A1Combination therapy using a factor xii inhibitor and a c-1 inhibitorCSL BEHRING GMBH·Filed 2019·Application pending·0 cites
- 0665US9452203B2Use of C1-inhibitor for the treatment of secondary edema of the central nervous systemCSL BEHRING GMBH·Filed 2012·Granted Sep 27, 2016·1 cites·30 claims
- 0765US9095564B2von Willebrand factor or factor VIII and von Willebrand factor for the treatment of coagulopathy induced by inhibitors of thrombocytesCSL BEHRING GMBH·Filed 2013·Granted Aug 4, 2015·1 cites·20 claims
- 0854US2016166660A1Combination therapy using a factor xii inhibitor and a c-1 inhibitorCSL BEHRING GMBH·Filed 2014·Application pending·0 cites
- 0935US2019183991A1Method of preventing acute attacks of hereditary angioedema associated with c1 esterase inhibitor deficiencyCSL BEHRING GMBH·Filed 2017·Application pending·0 cites
- 1029US2018036394A1Pharmaceutical formulations of c1 esterase inhibitorCSL BEHRING GMBH·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Ingo Pragst files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →